CEFIDEROCOL for Multiple-drug resistance: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 28 adverse event reports in the FDA FAERS database where CEFIDEROCOL was used for Multiple-drug resistance.
Most Reported Side Effects for CEFIDEROCOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 136 | 21.0% | 136 | 1 |
| Drug resistance | 66 | 10.2% | 22 | 12 |
| Treatment failure | 63 | 9.7% | 45 | 4 |
| Drug ineffective | 54 | 8.3% | 22 | 21 |
| Off label use | 52 | 8.0% | 24 | 11 |
| Pneumonia | 33 | 5.1% | 29 | 5 |
| Septic shock | 32 | 4.9% | 29 | 4 |
| Acute kidney injury | 30 | 4.6% | 10 | 17 |
| Multiple organ dysfunction syndrome | 30 | 4.6% | 30 | 2 |
| Pathogen resistance | 30 | 4.6% | 12 | 4 |
| No adverse event | 24 | 3.7% | 14 | 0 |
| Condition aggravated | 21 | 3.2% | 15 | 6 |
| Infection | 18 | 2.8% | 11 | 0 |
| Sepsis | 18 | 2.8% | 17 | 2 |
| Hepatic cytolysis | 13 | 2.0% | 0 | 10 |
Other Indications for CEFIDEROCOL
Pneumonia (111)
Pseudomonas infection (103)
Drug resistance (86)
Acinetobacter infection (65)
Product used for unknown indication (55)
Bacteraemia (50)
Klebsiella infection (43)
Bacterial infection (37)
Sepsis (35)
Pneumonia pseudomonal (25)